Filana Therapeutics earnings were -$91.0M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest FLNA earnings report on Dec 31, 2025 announced Q4 2025 earnings of -$12.5M, up 16% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, FLNA reported annual earnings of -$91.0M, with 273.7% growth. The next FLNA earnings date is May 7, 2026.
Filana Therapeutics Earnings Reports & History FAQ
What were Filana Therapeutics's earnings last quarter?
On FLNA's earnings call on Invalid Date, Filana Therapeutics (NASDAQ: FLNA) reported Q4 2025 earnings per share (EPS) of -$0.26, up 56.67% year over year. Total FLNA earnings for the quarter were -$12.54 million. In the same quarter last year, Filana Therapeutics's earnings per share (EPS) was -$0.60.
The next FLNA earnings call is Invalid Date. Add FLNA to your watchlist to be reminded of Filana Therapeutics's next earnings date.
Is Filana Therapeutics profitable or losing money?
As of the last Filana Therapeutics earnings report, Filana Therapeutics is currently losing money. Filana Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$90.97 million, a 273.73% increase year over year.
What was FLNA's earnings growth in the past year?
As of Filana Therapeutics's earnings date in Invalid Date, Filana Therapeutics's earnings has grown year over year. FLNA earnings in the past year totalled -$90.97 million.
What are Filana Therapeutics's earnings expectations?
The current EPS estimate for Filana Therapeutics's earnings report in Invalid Date is -$0.30.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.